Da­ta do not sup­port wide­spread Covid vac­cine boost­ers right now, out­go­ing FDA lead­ers write in the Lancet

Even with the Delta vari­ant, vac­cine ef­fi­ca­cy against se­vere Covid-19 is so high that boost­er dos­es for the gen­er­al pop­u­la­tion are not ap­pro­pri­ate at this stage in the pan­dem­ic, the FDA’s two top vac­cine lead­ers, who re­cent­ly an­nounced their up­com­ing re­tire­ments on the same day, wrote in the Lancet on Mon­day.

The view­point, which was al­so co-au­thored by WHO and oth­er aca­d­e­m­ic ex­perts from around the world, comes as the FDA is con­sid­er­ing au­tho­riz­ing the use of boost­ers, with an ad­comm of out­side ex­perts due to weigh in on Fri­day (brief­ing docs com­ing Wednes­day).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER